Detalhe da pesquisa
1.
Plasma pTau-217 and N-terminal tau (NTA) enhance sensitivity to identify tau PET positivity in amyloid-ß positive individuals.
Alzheimers Dement
; 20(2): 1166-1174, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37920945
2.
Prevalence of orofacial pain in individuals with mild cognitive impairment or dementia: A systematic review and meta-analysis.
Gerodontology
; 2024 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38247027
3.
14-3-3 [Formula: see text]-reported early synaptic injury in Alzheimer's disease is independently mediated by sTREM2.
J Neuroinflammation
; 20(1): 278, 2023 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38001539
4.
Plasma and CSF concentrations of N-terminal tau fragments associate with in vivo neurofibrillary tangle burden.
Alzheimers Dement
; 19(12): 5343-5354, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37190913
5.
Equivalence of plasma p-tau217 with cerebrospinal fluid in the diagnosis of Alzheimer's disease.
Alzheimers Dement
; 19(11): 4967-4977, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37078495
6.
Plasma p-tau231 and p-tau217 inform on tau tangles aggregation in cognitively impaired individuals.
Alzheimers Dement
; 19(10): 4463-4474, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37534889
7.
Blood-brain barrier integrity impacts the use of plasma amyloid-ß as a proxy of brain amyloid-ß pathology.
Alzheimers Dement
; 19(9): 3815-3825, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36919582
8.
Comparison of immunoassay- with mass spectrometry-derived p-tau quantification for the detection of Alzheimer's disease pathology.
Mol Neurodegener
; 19(1): 2, 2024 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38185677
9.
Predicting functional decline in aging and Alzheimer's disease with PET-based Braak staging.
Brain Commun
; 6(2): fcae043, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38482373
10.
The Use of Tau PET to Stage Alzheimer Disease According to the Braak Staging Framework.
J Nucl Med
; 64(8): 1171-1178, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37321820
11.
Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography.
JAMA Neurol
; 80(2): 188-199, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36508198
12.
APOEε4 potentiates amyloid ß effects on longitudinal tau pathology.
Nat Aging
; 3(10): 1210-1218, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37749258